Background Continuous-flow left ventricular assist devices (CF-LVADs) have become the
standard of care for patients with end-stage heart failure (HF). While these devices have …

BACKGROUND: Continuous flow left ventricular assist devices (CF-LVADs) have yielded
improved outcomes compared with pulsatile flow devices for patients on long-term support …

While technological advances in the field of continuous‐flow left ventricular assist device
(CF‐LVAD) are constantly being made, CF‐LVAD recipients are still subjected to a relatively …

Gastrointestinal bleeding (GIB) remains a significant problem after continuous-flow left
ventricular assist device (CF-LVAD) implantation. We hypothesized that the subsequent …

BACKGROUND: Left ventricular assist devices (LVADs) have revolutionized the
management of end-stage heart failure (ESHF). However, unexpectedly high rates of GI …

Objectives To evaluate rate, recurrence, and predictors of gastrointestinal bleeding (GIB)
and impact of endoscopy in left ventricular assist device (LVAD) patients. Methods This is a …

Left ventricular assist devices (LVADs) are associated with hemostatic complications. We
describe the incidence and risk factors for gastrointestinal bleeding (GIB) and pump …

Increasing use of left ventricular assist devices (LVADs) has been accompanied by rising
incidence of gastrointestinal bleeding (GIB). Objectives of this study were to determine the …

Background Continuous-flow left ventricular assist devices (CF-LVAD) have become the
standard of care for patients with end stage heart failure. Device reliability has increased …

Continuous-flow (CF) left ventricular assist device (LVAD) therapy for patients with advanced
heart failure continues to increase both as a bridge to transplant (BTT) and as destination …